International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

This publication has 116 references indexed in Scilit:

• Clinical Significance of Anticardiolipin and Anti-β2-Glycoprotein I Antibodies
  International Archives of Allergy and Immunology, 2004
• Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)
  Published by Elsevier ,2004
• Consensus guidelines on anti-cardiolipin antibody testing and reporting
  Pathology, 2004
• Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
  Hypertension, 2003
• Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods
  British Journal of Haematology, 2002
• Prevalence and clinical significance of anticardiolipin and anti-β2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma
  European Journal of Haematology, 2002
• A chimeric antibody with the human ?1 constant region as a putative standard for assays to detect IgG ?2-glycoprotein I-dependent anticardiolipin and anti-?2-glycoprotein I antibodies
  Arthritis & Rheumatism, 1999
• International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop
  Arthritis & Rheumatism, 1999
• Do antibodies to β2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome?
  Lupus, 1999
• IgG Anticardiolipin Antibody Titer >40 GPL and the Risk of Subsequent Thrombo-occlusive Events and Death
  Stroke, 1997